Infective endocarditis prophylaxis: a review

References

• Bin Abdulhak AA, Baddour LM, Erwin PJ, et al. Global and regional burden of infective endocarditis, 1990–2010: a systematic review of the literature. Glob Heart. 2014;9(1):131–143.
   PubMedGoogle Scholar
• Bannay A, Hoen B, Duval X, et al. The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J. 2011;32(16):2003–2015.
   PubMed Web of Science ®Google Scholar
• Damasco PV, Ramos JN, Correal JCD, et al. Infective endocarditis in Rio de Janeiro, Brazil: a 5-year experience at two teaching hospitals. Infection. 2014;42(5):835–842.
   PubMed Web of Science ®Google Scholar
• Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med. 2009;169(5):463–473.
   PubMedGoogle Scholar
• Olmos C, Vilacosta I, Fernández C, et al. Comparison of clinical features of left-sided infective endocarditis involving previously normal versus previously abnormal valves. Am J Cardiol. 2014;114(2):278–283.
   PubMed Web of Science ®Google Scholar
• Delahaye F, M’Hammedi A, Guerpillon B, et al. Systematic search for present and potential portals of entry for infective endocarditis. J Am Coll Cardiol. 2016;67(2):151–158.
   PubMed Web of Science ®Google Scholar
• Thornhill MH, Dayer MJ, Prendergast B, et al. Incidence and nature of adverse reactions to antibiotics used as endocarditis prophylaxis. J Antimicrob Chemother. 2015;70(8):2382–2388.
   PubMed Web of Science ®Google Scholar
• Delahaye F, Harbaoui B, Cart-Regal V, et al. Recommendations on prophylaxis for infective endocarditis: dramatic changes over the past seven years. Arch Cardiovasc Dis. 2009;102(3):233–245.
   PubMed Web of Science ®Google Scholar
• Jones TD, Baumgartner L, Bellows MT, et al. Committee on prevention of rheumatic fever and bacterial endocarditis, American Heart Association). Prevention of rheumatic fever and bacterial endocarditis through control of streptococcal infections. Circulation. 1955;11:317–320.
   Web of Science ®Google Scholar
• Steckelberg JM, Wilson WR. Risk factors for infective endocarditis. Infect Dis Clin North Am. 1993;7(1):9–19.
   PubMed Web of Science ®Google Scholar
• Lockhart PB, Brennan MT, Kent ML, et al. Impact of amoxicillin prophylaxis on the incidence, nature, and duration of bacteremia in children after intubation and dental procedures. Circulation. 2004;109(23):2878–2884.
   PubMed Web of Science ®Google Scholar
• Roberts GJ, Jaffray EC, Spratt DA, et al. Duration, prevalence and intensity of bacteraemia after dental extractions in children. Heart. 2006;92(9):1274–1277.
   PubMed Web of Science ®Google Scholar
• Durack DT, Beeson PB. Experimental bacterial endocarditis. II. Survival of a bacteria in endocardial vegetations. Br J Exp Pathol. 1972;53(1):50–53.
   PubMedGoogle Scholar
• Glenny AM, Oliver R, Roberts GJ, et al. Antibiotics for the prophylaxis of bacterial endocarditis in dentistry. Cochrane Database Syst Rev. 2013;(10):Cd003813.doi: 10.1002/14651858.CD003813.pub4
   Google Scholar
• Van der Meer JT, Van Wijk W, Thompson J, et al. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet. 1992;339(8786):135–139.
   PubMed Web of Science ®Google Scholar
• Duval X, Alla F, Hoen B, et al. Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis. Clin Infect Dis. 2006;42(12):e102–7.
   Google Scholar
• Strom BL, Abrutyn E, Berlin JA, et al. Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study. Ann Intern Med. 1998;129(10):761–769.
   PubMed Web of Science ®Google Scholar
• Lockhart PB, Brennan MT, Sasser HC, et al. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008;117(24):3118–3125.
   PubMed Web of Science ®Google Scholar
• Roberts JG. Dentists are innocent! “Everyday” bacteremia is the real culprit: a review and assessment of the evidence that dental surgical procedures are a principal cause of bacterial endocarditis in children. Pediatr Cardiol. 1999;20(5):317–325.
   PubMed Web of Science ®Google Scholar
• Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association rheumatic fever, endocarditis, and kawasaki disease committee, council on cardiovascular disease in the young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group. Circulation. 2007;116(15):1736–1754.
   PubMed Web of Science ®Google Scholar
• Société de pathologie infectieuse de langue, f. Prophylaxie de l’endocardite infectieuse Révision de la conférence de consensus de mars 1992 Recommandations 2002. Annales Françaises d’anesthésie et de réanimation. 2003;22(10):920–929.
   PubMedGoogle Scholar
• Danchin N, Duval X, Leport C. Prophylaxis of infective endocarditis: french recommendations 2002. Heart. 2005;91(6):715–718.
   PubMed Web of Science ®Google Scholar
• Gould FK, Elliott TSJ, Foweraker J, et al. Guidelines for the prevention of endocarditis: report of the working party of the British society for Antimicrobial chemotherapy. J Antimicrob Chemother. 2006;57(6):1035–1042.
   PubMed Web of Science ®Google Scholar
• Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA. 1997;277(22):1794–1801.
   PubMed Web of Science ®Google Scholar
• Centre for Clinical Practice at NICE. National institute for health and clinical excellence: guidance, in prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. London: National Institute for Health and Clinical Excellence (UK) National Institute for Health and Clinical Excellence; 2008.
   Google Scholar
• Centre for Clinical Practice at NICE. National institute for health and clinical excellence: guidance, in prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. London: National Institute for Health and Clinical Excellence (UK)National Institute for Health and Clinical Excellence; 2016.
   Google Scholar
• Thornhill MH, Dayer M, Lockhart PB, et al. A change in the NICE guidelines on antibiotic prophylaxis. Br Dent J. 2016;221(3):112–114.
   PubMed Web of Science ®Google Scholar
• Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for infection and cancer. Eur Heart J. 2009;30(19):2369–2413.
   PubMed Web of Science ®Google Scholar
• Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis. http://www.w3.org/1999/xhtml The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM), 2015.
   Google Scholar
• Dayer MJ, Jones S, Prendergast B, et al. Incidence of infective endocarditis in England, 2000–13: a secular trend, interrupted time-series analysis. Lancet. 2015;385(9974):1219–1228.
   PubMed Web of Science ®Google Scholar
• Thornhill MH, Dayer MJ, Forde JM, et al. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ. 2011;342:d2392.
   PubMed Web of Science ®Google Scholar
• Grattan MJ, Power A, Fruitman DS, et al. The impact of infective endocarditis prophylaxis recommendations on the practices of pediatric and adult congenital cardiologists. Can J Cardiol. 2015;31(12):1497.e23–8.
   PubMed Web of Science ®Google Scholar
• Desimone DC, Tleyjeh IM, Correa De Sa DD, et al. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association’s endocarditis prevention guidelines. Circulation. 2012;126(1):60–64.
   PubMed Web of Science ®Google Scholar
• Pharis CS, Conway J, Warren AE, et al. The impact of 2007 infective endocarditis prophylaxis guidelines on the practice of congenital heart disease specialists. Am Heart J. 2011;161(1):123–129.
   PubMed Web of Science ®Google Scholar
• Rogers AM, Schiller NB. Impact of the first nine months of revised infective endocarditis prophylaxis guidelines at a university hospital: so far so good. J Am Soc Echocardiogr. 2008;21(6):775.
   PubMed Web of Science ®Google Scholar
• Keller K, Von Bardeleben RS, Ostad MA, et al. Temporal trends in the prevalence of infective endocarditis in Germany between 2005 and 2014. Am J Cardiol. 2017;119(2):317–322.
   PubMedGoogle Scholar
• van den Brink FS, Swaans MJ, Hoogendijk MG, et al. Increased incidence of infective endocarditis after the 2009 European society of cardiology guideline update: a nation-wide study in the Netherlands. Eur Heart J Qual Care Clin Outcomes. 2016.doi: http://dx.doi.org/10.1093/ehjqcco/qcw039 qcw039
   PubMedGoogle Scholar
• Mackie AS, Liu W, Savu A, et al. Infective endocarditis hospitalizations before and after the 2007 American heart association prophylaxis guidelines. Can J Cardiol. 2016;32(8):942–948.
   PubMed Web of Science ®Google Scholar
• Pant S, Patel NJ, Deshmukh A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65(19):2070–2076.
   PubMed Web of Science ®Google Scholar
• Bor DH, Woolhandler S, Nardin R, et al. Infective endocarditis in the U.S., 1998–2009: a nationwide study. Plos One. 2013;8(3):e60033.
   PubMed Web of Science ®Google Scholar
• Bikdeli B, Wang Y, Kim N, et al. Trends in hospitalization rates and outcomes of endocarditis among Medicare beneficiaries. J Am Coll Cardiol. 2013;62(23):2217–2226.
   PubMed Web of Science ®Google Scholar
• Duval X, Delahaye F, Alla F, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59(22):1968–1976.
   PubMed Web of Science ®Google Scholar
• Pasquali SK, He X, Mohamad Z, et al. Trends in endocarditis hospitalizations at US children’s hospitals: impact of the 2007 American heart association antibiotic prophylaxis guidelines. Am Heart J. 2012;163(5):894–899.
   PubMed Web of Science ®Google Scholar
• Selton-Suty C, Célard M, Le Moing V, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230–1239.
   PubMed Web of Science ®Google Scholar
• Pericas JM, Falces C, Moreno A, et al. Neglecting enterococci may lead to a misinterpretation of the consequences of last changes in endocarditis prophylaxis American heart association guidelines. J Am Coll Cardiol. 2015;66(19):2156.
   PubMed Web of Science ®Google Scholar
• Mackie AS, Liu W, Savu A, et al., Reply to Letter From Thornhill et al.—infective endocarditis hospitalizations before and after the 2007 American heart association prophylaxis guidelines. Can J Cardiol. 2014;32(12):1578.e11. Reply to Letter From Thornhill.
   Web of Science ®Google Scholar
• Slipczuk L, Codolosa JN, Davila CD, et al. Infective endocarditis epidemiology over five decades: a systematic review. Plos One. 2013;8(12):e82665.
   PubMedGoogle Scholar
• Khan O, Shafi AM, Timmis A. International guideline changes and the incidence of infective endocarditis: a systematic review. Open Heart. 2016;3(2):e000498.
   Google Scholar
• Opatowski L, Mandel J, Varon E, et al. Antibiotic dose impact on resistance selection in the community: a mathematical model of β-lactams and streptococcus pneumoniae dynamics. Antimicrob Agents Chemother. 2010;54(6):2330–2337.
   PubMed Web of Science ®Google Scholar
• Guillemot D, Carbon C, Balkau B, et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA. 1998;279(5):365–370.
   PubMed Web of Science ®Google Scholar
• Harbarth S, Samore MH, Lichtenberg D, et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000;101(25):2916–2921.
   PubMed Web of Science ®Google Scholar
• Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882–893.
   PubMed Web of Science ®Google Scholar
• Thornhill MH, Lockhart PB, Prendergast B, et al. NICE and antibiotic prophylaxis to prevent endocarditis. Br Dent J. 2015;218(11):619–621.
   PubMed Web of Science ®Google Scholar
• Franklin M, Wailoo A, Dayer MJ, et al. The cost-effectiveness of antibiotic prophylaxis for patients at risk of infective endocarditis. Circulation. 2016;134(20):1568–1578.
   PubMed Web of Science ®Google Scholar